刀豆素A结构式
|
常用名 | 刀豆素A | 英文名 | concanamycin A |
|---|---|---|---|---|
| CAS号 | 80890-47-7 | 分子量 | 866.09 | |
| 密度 | 1.2±0.1 g/cm3 | 沸点 | 966.4±65.0 °C at 760 mmHg | |
| 分子式 | C46H75NO14 | 熔点 | 179-180℃ (dichloromethane ethanol ) | |
| MSDS | 中文版 美版 | 闪点 | 538.3±34.3 °C | |
| 符号 |
GHS06 |
信号词 | Danger |
刀豆素A用途Concanamycin A (Antibiotic X 4357B; Concanamycin; X 4357B) 是一种大环内酯类抗生素,也是特异的空泡状 H+- ATP 酶 (V-ATPase) 抑制剂。 |
| 中文名 | 伴刀球霉素A |
|---|---|
| 英文名 | concanamycin A |
| 中文别名 | 刀豆素A |
| 英文别名 | 更多 |
| 描述 | Concanamycin A (Antibiotic X 4357B; Concanamycin; X 4357B) 是一种大环内酯类抗生素,也是特异的空泡状 H+- ATP 酶 (V-ATPase) 抑制剂。 |
|---|---|
| 相关类别 | |
| 靶点 |
Vacuolar type H+-ATPase[1] |
| 参考文献 |
| 密度 | 1.2±0.1 g/cm3 |
|---|---|
| 沸点 | 966.4±65.0 °C at 760 mmHg |
| 熔点 | 179-180℃ (dichloromethane ethanol ) |
| 分子式 | C46H75NO14 |
| 分子量 | 866.09 |
| 闪点 | 538.3±34.3 °C |
| 精确质量 | 865.518738 |
| PSA | 225.92000 |
| LogP | 3.88 |
| InChIKey | DJZCTUVALDDONK-VHHURPMASA-N |
| SMILES | CC=CC1OC(O)(C(C)C(O)C(C)C2OC(=O)C(OC)=CC(C)=CC(C)C(O)C(CC)C(O)C(C)CC(C)=CC=CC2OC)CC(OC2CC(O)C(OC(N)=O)C(C)O2)C1C |
| 蒸汽压 | 0.0±0.6 mmHg at 25°C |
| 折射率 | 1.555 |
| 储存条件 | 密闭,干燥,-20°C冷藏 |
| 稳定性 | 按规定使用和贮存的不会分解,避氧化物 |
| 计算化学 | 1、 疏水参数计算参考值(XlogP):6 2、 氢键供体数量:6 3、 氢键受体数量14 4、 可旋转化学键数量:12 5、 互变异构体数量:2 6、 拓扑分子极性表面积(TPSA):226 7、 重原子数量:61 8、 表面电荷:0 9、 复杂度:1580 10、同位素原子数量:0 11、确定原子立构中心数量:17 12、不确定原子立构中心数量1 13、确定化学键立构中心数量:5 14、不确定化学键立构中心数量:0 15、共价键单元数量:1 |
| 更多 | 1. 性状:白色晶体 2. 密度(g/Ml25ºC):未确定 3. 相对蒸汽密度(g/mL,空气=1):未确定 4. 熔点(ºC):268 5. 沸点(ºC,常压):未确定 6. 沸点(ºC12mmHg)未确定 7. 折射率:未确定 8. 闪点(º C):未确定 9. 比旋光度(º):未确定 10. 自燃点或引燃温度(ºC):未确定 11. 蒸气压(kPa,):未确定 12. 饱和蒸气压(kPa,60ºC):未确定 13. 燃烧热(KJ/mol):未确定 14. 临界温度(ºC):未确定 15. 临界压力(KPa):未确定 16. 油水(正辛醇/水)分配系数的对数值:未确定 17. 爆炸上限(%,V/V):未确定 18. 爆炸下限(%,V/V):未确定 19. 溶解性:未确定 |
| 符号 |
GHS06 |
|---|---|
| 信号词 | Danger |
| 危害声明 | H300 + H310 + H330-H319 |
| 警示性声明 | P260-P264-P280-P284-P301 + P310-P302 + P350 |
| 个人防护装备 | Eyeshields;Faceshields;full-face particle respirator type N100 (US);Gloves;respirator cartridge type N100 (US);type P1 (EN143) respirator filter;type P3 (EN 143) respirator cartridges |
| 危害码 (欧洲) | T+ |
| 风险声明 (欧洲) | 26/27/28-36 |
| 安全声明 (欧洲) | 26-36/37/39-45 |
| 危险品运输编码 | UN 3462 6.1/PG 2 |
| WGK德国 | 3 |
| RTECS号 | CB9732000 |
| 包装等级 | III |
| 危险类别 | 6.1(b) |
|
2,4-Dichlorophenoxyacetic acid alters intracellular pH and ion transport in the outer mantle epithelium of the bivalve Anodonta cygnea.
Aquat. Toxicol. 154 , 12-8, (2014) Bivalve molluscs, due to their sedentary mode of life and filter-feeding behavior, are very susceptible to pollutant bioaccumulation and used as sentinel organisms in the assessment of environment pol... |
|
|
Inhibitors of vacuolar ATPase proton pumps inhibit human prostate cancer cell invasion and prostate-specific antigen expression and secretion.
Int. J. Cancer 132(2) , E1-10, (2013) Vacuolar ATPases (V-ATPases) comprise specialized and ubiquitously distributed pumps that acidify intracellular compartments and energize membranes. To gain new insights into the roles of V-ATPases in... |
|
|
Functional characterization of the Plasmodium falciparum chloroquine-resistance transporter (PfCRT) in transformed Dictyostelium discoideum vesicles.
PLoS ONE 7(6) , e39569, (2012) Chloroquine (CQ)-resistant Plasmodium falciparum malaria has been a global health catastrophe, yet much about the CQ resistance (CQR) mechanism remains unclear. Hallmarks of the CQR phenotype include ... |
| antibioticx4357b |
| S-45A |
| MFCD00210037 |
| Antibiotic A661I |
| (5R)-3-O-(4-O-Carbamoyl-2,6-dideoxy-β-D-arabino-hexopyranosyl)-2,4-dideoxy-1-C-{(2S,3R,4S)-4-[(2R,3S,4E,6E,9R,10S,11S,12R,13R,14E,16Z)-11-ethyl-10,12-dihydroxy-3,17-dimethoxy-7,9,13,15-tetramethyl-18-oxooxacyclooctadeca-4,6,14,16-tetraen-2-yl]-3-hydroxypentan-2-yl}-4-methyl-5-[(1E)-prop-1-en-1-yl]-α-D-threo-pentopyranose |
| FOLIMYCIN,STREPTOMYCES SP |
| α-D-threo-Pentopyranose, 3-O-[4-O-(aminocarbonyl)-2,6-dideoxy-β-D-arabino-hexopyranosyl]-2,4-dideoxy-1-C-[(1S,2R,3S)-3-[(2R,3S,4E,6E,9R,10S,11S,12R,13R,14E,16Z)-11-ethyl-10,12-dihydroxy-3,17-dimethoxy-7,9,13,15-tetramethyl-18-oxooxacyclooctadeca-4,6,14,16-tetraen-2-yl]-2-hydroxy-1-methylbutyl]-4-methyl-5-C-[(1E)-1-propen-1-yl]-, (5R)- |
| A661-I |
| FOLIMYCIN |
| Antibiotic S-45A |
| x4357b |
| α-D-threo-Pentopyranose, 3-O-[4-O-(aminocarbonyl)-2,6-dideoxy-β-D-arabino-hexopyranosyl]-2,4-dideoxy-1-C-[(1S,2R,3S)-3-[(2R,3S,4E,6E,9R,10S,11S,12R,13R,14E,16Z)-11-ethyl-10,12-dihydroxy-3,17-di methoxy-7,9,13,15-tetramethyl-18-oxooxacyclooctadeca-4,6,14,16-tetraen-2-yl]-2-hydroxy-1-methylbutyl]-4-methyl-5-C-[(1E)-1-propen-1-yl]-, (5R)- |
| Concanamycin A,(3Z,5E,7R,8R,9S,10S,11R,13E,15E,17S,18R)-18-[(1S,2R,3S)-3-[(2R,4R,5S,6R)-4-[[4-O-(Aminocarbonyl)-2,6-dideoxy-β-D-arabino-hexopyranosyl]oxy]tetrahydro-2-hydroxy-5-methyl-6-(1E)-1-propenyl-2H-pyran-2-yl]-2-hydroxy-1-methylbutyl]-9-ethyl-8,10- |
| CONCANAMYCIN A |
| (5R)-3-O-(4-O-Carbamoyl-2,6-dideoxy-β-D-arabino-hexopyranosyl)-2,4-dideoxy-1-C-{(2S,3R,4S)-4-[(2R,3S,4E,6E,9R,10S,11S,12R,13R,14E,16Z)-11-ethyl-10,12-dihydroxy-3,17-dimethoxy-7,9,13,15-tetramethyl- 18-oxooxacyclooctadeca-4,6,14,16-tetraen-2-yl]-3-hydroxy-2-pentanyl}-4-methyl-5-[(1E)-1-propen-1-yl]-α-D-threo-pentopyranose |